Riskpilot← Back to searchSign inGet full accessIsis-tutkimus Oy
OYDissolvedY-tunnus 0796997-3Kruunuvuorenkatu 3-A5Medical specialists activities · NACE 8622Est. 19901 employees
Revenue 2025
EUR 85K
-3% vs 2024
EBITDA margin
81.1%
-23% vs 2024
Equity ratio
96.4%
Financial strength
Net profit 2025
EUR 117K
+8% vs 2024
| Revenue | EUR 85K | -3% |
| EBITDA | EUR 69K | -23% |
| Net profit | EUR 117K | +8% |
| Total assets | EUR 599K | +17% |
| Equity | EUR 577K | +15% |
| Employees | 1 | — |
Legal name
Isis-tutkimus Oy
Y-tunnus number
0796997-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
9. toukokuuta 1990
Share capital
EUR 8 409
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Yhtiön toimialana on lääkäritoimen harjoittaminen, lääketieteellinen tutkimus-, konsultaatio- sekä luento- ja koulutustoiminta, filosofinen tutkimus- ja konsultaatio, alan oppimateriaalin tuottaminen sekä luento- ja koulutustilaisuuksien järjestäminen, henkilöstöpalvelut, kodinhoito- ja siivouspalvelut, juhlatilaisuuksien järjestäminen, musiikkialan palvelut, äänituotanto, musiikkituotanto ja musiikkitilaisuuksien järjestäminen, arvopaperikauppa, antiikin ja taiteen maahantuonti ja kauppa, asuin-, liike- sekä vapaa-ajan huoneistojen ja kiinteistöjen kauppa, hallinta, vuokraus, sisustus ja kunnostus.
Address
Kruunuvuorenkatu 3-A5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 68 | 89 | 88 | 89 | 85 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 65 | 121 | 80 | 90 | 69 |
| Depreciation & amort. | −1 | −2 | −2 | 1 | −1 |
| EBIT | 63 | 119 | 78 | 92 | 68 |
| Net financials | 6 | −9 | −10 | 43 | 78 |
| Profit before tax | 69 | 110 | 68 | 135 | 147 |
| Tax | 14 | 22 | 14 | 27 | 30 |
| Net profit | 55 | 88 | 54 | 108 | 117 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 290 | 364 | 38 400 | 510 | 599 |
| Equity | 277 | 342 | 372 | 501 | 577 |
| Long-term debt | 11 | 11 | 5 | 5 | 5 |
| Short-term debt | 1 | 10 | 7 | 4 | 17 |
| Total debt | 12 | 21 | 12 | 9 | 21 |
EBITDA margin
81.1%
This company
15.8%
Market median
+413% vs market
20212025
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
136.5%
This company
8.1%
Market median
+1585% vs market
20212025
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MT Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
SH Deputy Member | Deputy Member | 1998 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairperson | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Isis-tutkimus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sinikka Hannele Pohjola-Sintonen | Deputy Member | 0 companies |
| Matti Tapani Sintonen | Chief Executive Officer | 0 companies |
| Matti Sakari Sintonen | Board of Directors | 0 companies |
| Aino Kaarina Liimatainen | Chairperson | 0 companies |